Targeting One
Haidian
About Targeting One
Targeting One is a joint-stock technology firm that creates reagents, software, and other products. It is committed to developing products in the life science and molecular diagnostic enterprise, serving life science, precision medicine, drug development, and health management, by developing molecular diagnostic technologies with multiple indicators, high throughput, automation, pollution prevention, and relatively inexpensive.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $37.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2024)
- Website: targetingone.com
- Phone: 010-82481061
Industries & Categories
Biotechnology, Genetics, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/targeting-one-79429 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.